Private equity buyers up Biomet offer
This article was originally published in Clinica
Executive Summary
Biomet has accepted a sweetened bid made by its private equity suitor that boosts the transaction value to $11.4bn. The revised offer comes only a week after the original $10.9bn proposal, made in December 2006, was criticised by an independent proxy company (see Clinica No 1259, p 15).